(NYSE: CHE) Chemed's forecast annual revenue growth rate of 5.06% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.17%.
Chemed's revenue in 2026 is $2,661,041,000.On average, 6 Wall Street analysts forecast CHE's revenue for 2026 to be $35,934,180,315, with the lowest CHE revenue forecast at $34,788,867,795, and the highest CHE revenue forecast at $37,443,910,455. On average, 6 Wall Street analysts forecast CHE's revenue for 2027 to be $38,315,909,760, with the lowest CHE revenue forecast at $36,767,134,875, and the highest CHE revenue forecast at $40,294,176,840.
In 2028, CHE is forecast to generate $40,411,311,075 in revenue, with the lowest revenue forecast at $38,745,401,955 and the highest revenue forecast at $42,753,995,775.